Additionally, combining iron- and inflammation-related gene signatures with markers of epithelial proliferation (e.g., MKI67) and DNA damage (e.g., γ-H2AX) could form a highly specific multi-analyte panel for detecting CRC in high-risk populations [143]. This evidence concerns the gene H2AX and colorectal carcinoma.